期刊文献+

Expression and correlation of CD44v6, vascular endothelial growth factor, matrix metalloproteinase-2, and matrix metalloproteinase-9 in Krukenberg tumor 被引量:20

Expression and correlation of CD44v6, vascular endothelial growth factor, matrix metalloproteinase-2, and matrix metalloproteinase-9 in Krukenberg tumor
下载PDF
导出
摘要 AIM: To explore the expression and correlation of CD44v6, vascular endothelial growth factor (VEGF), matrix metalloproteinase (MMP)-2 and matrix metalloproteinase (MMP)-9 in Krukenberg and primary epithelial ovarian carcinoma. METHODS: The expressions of CD44v6, VEGF, MMP-2 and MMP-9 were detected by immunohistochemical method in 20 cases of normal ovarian tissues, 38 cases of Krukenberg tumor and 45 cases of primary epithelial ovarian carcinoma. RESULTS: The expression of CD44v6 (primary epithelial ovarian carcinoma tissue vs normal ovarian tissue: χ^2= 4.516, P= 0.034; Krukenberg tumor tissue vsnormal ovarian tissue: χ^2 = 19.537, P = 0.001) and VEGF (primary epithelial ovarian carcinoma tissue vs normal ovarian tissue: P = 0.026; Krukenberg tumor tissue vs normal ovarian tissue: χ^2 = 22.895, P = 0.001) was significantly higher in primary epithelial ovarian carcinoma tissue and Krukenberg tumor tissue than in normal ovarian tissue. The positive expression rate of MMP-2 and MMP-9 was 0% in the normal ovarian tissue. The positive expression rate of CD44v6 ( χ^2= 10.398, P= 0.001), VEGF ( χ^2= 13.149, P = 0.001), MMP-2 ( χ^2 = 33.668, P = 0.001) and MMP-9 ( χ^2= 38.839, P = 0.001) was remarkably higher in Krukenberg tumor than in primary epithelial ovarian carcinoma. The correlation of CD44v6, VEGF, MMP-2, and MMP-9 was observed in primary epithelial ovarian carcinoma and Krukenberg tumor. CONCLUSION: CD44v6, VEGF, MMP-2, and MMP-9 are involved in ovarian carcinoma, gastric cancer and Krukenberg tumor. Detection of CD44v6, VEGF, MMP-2 and MMP-9 may contribute to the diagnosis of ovarian carcinoma, gastric cancer, and Krukenberg tumor. AIM: To explore the expression and correlation of CD44v6,vascular endothelial growth factor (VEGF), matrix metalloproteinase (MMP)-2 and matrix metalloproteinase (MMP)-9 in Krukenberg and primary epithelial ovarian carcinoma.METHODS: The expressions of CD44v6, VEGF, MMP-2and MMP-9 were detected by immunohistochemical method in 20 cases of normal ovarian tissues, 38 cases of Krukenberg tumor and 45 cases of primary epithelial ovarian carcinoma.RESULTS: The expression of CD44v6 (primary epithelial ovarian carcinoma tissue vs normal ovarian tissue:x2= 4.516, P= 0.034; Krukenberg tumor tissue vsnormal ovarian tissue: x2 = 19.537, P= 0.001) and VEGF (primary epithelial ovarian carcinoma tissue vs normal ovarian tissue: P = 0.026; Krukenberg tumor tissue vs normal ovarian tissue: x2= 22.895, P = 0.001) was significantly higher in primary epithelial ovarian carcinoma tissue and Krukenberg tumor tissue than in normal ovarian tissue.The positive expression rate of MMP-2 and MMP-9 was 0%in the normal ovarian tissue. The positive expression rate of CD44v6 (x2 = 10.398, P = 0.001), VEGF (x2 = 13.149,P= 0.001), MMP-2 (x2= 33.668, P= 0.001) and MMP-9(x2= 38.839, P = 0.001) was remarkably higher in Krukenberg tumor than in primary epithelial ovarian carcinoma. The correlation of CD44v6, VEGF, MMP-2, and MMP-9 was observed in primary epithelial ovarian carcinoma and Krukenberg tumor.CONCLUSION: CD44v6, VEGF, MMP-2, and MMP-9 are involved in ovarian carcinoma, gastric cancer and Krukenberg tumor. Detection of CD44v6, VEGF, MMP-2and MMP-9 may contribute to the diagnosis of ovarian carcinoma, gastric cancer, and Krukenberg tumor.
出处 《World Journal of Gastroenterology》 SCIE CAS CSCD 2005年第32期5032-5036,共5页 世界胃肠病学杂志(英文版)
基金 Supported by Foundation for Scholars Abroad of Ministry of Education of China, No. [2003]406Foundation of Heilongjiang Office of Education, No. 9551138
关键词 CD44V6 VEGF MMPs Krukenberg tumor CD44v6 基因表达 血管内皮生长因子 金属蛋白酶-2 金属蛋白酶-9 克鲁肯伯格氏瘤 黏液细胞瘤
  • 相关文献

参考文献7

二级参考文献118

  • 1邓大君,朱少侠,陈强,张汝黻.MNNG诱发新生大鼠腺胃癌模型的建立及其在胃癌发病机制研究上的应用[J].中华病理学杂志,1994,23(5):293-295. 被引量:23
  • 2Weidner N, Semple JP, Welch WR, et al. Tumor angiogenesis and metastasis- correlation in invasive breast carcinoma[J]. N Engl J Med. 1991.324(1): 1 -8.
  • 3Kitamura K, Yamaguchi T, Taniguchi H, et al. Analysis of lymph node metastasis in early gastric cancer: rationale of imitated surgery [ J ]. J Surg Onclo, 1997,64 ( 1 ): 42 - 49.
  • 4Kaipainen A, Korhoren J, Taipale J, et al. Expression of the fins-like tyrosine kinase FLT-4 gene becomes restricted to endothelium of lymphatic vessels during development[J] . Proc Natl Acad Sci USA, 1995, 92(8): 3566- 3570.
  • 5Fisher ER. Detection and significance of occult axillary node metastasis in patients with invasive breast cancer[J]. Cancer,1978, 42: 2025.
  • 6Joukov V, Pajusola K, Kaipainen A, et al. A novel Vasculax endothelial growth factor, VEGF-C, is a ligand for the FLT4(VEGFR-3) and KDR(VEGFR-2) receptor tyrosine jinases[J] .EMBO J, 1996,15 (2): 290 - 298.
  • 7Jian-Feng Wang. Ganju RK, Zhong-Ying Liu, et al. Signal transduction in human hematopoietic cells by vascular endothelial growth factor related protein, a novel ligand for the FLT4 receptor[J]. Blood, 1997,90(9): 3507 - 3515.
  • 8Partanen TA, Arola J, Saaristo A, et al. VEGF-C and VEGF-D expression in neuroendocrine cells and their receptor, VEGFR-3, in fenestrated blood vessels in human tissues[J] .FASEB J, 2000, 14( 13): 2087 - 2097.
  • 9Tsurusaki T, Kanda S, Sakai H, et al. Vascular endothelial growth factor-C expression in human prostatic carcinoma and its relationship to lymph node metastasis[J]. British J Cancer, 1999,80(1/2): 309 - 313.
  • 10Kitadai Y, Amioka T, Haruma K, et al. Clinicopatholagical significance of vascular endothelial growth factor (VEGF) -C in human esophageal squamous cell carcinomas[J] . Int J Cancer,2001, 93(5): 662 - 666.

共引文献108

同被引文献94

引证文献20

二级引证文献88

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部